None Pill — RED CAPSULE, 17mm — Omeprazole
| Imprint | None |
|---|---|
| Colour | RED |
| Shape | CAPSULE |
| Size | 17 |
| Strength | OMEPRAZOLE 20 mg;DIETHYL PHTHALATE 0.144 mg;SODIUM LAURYL SULFATE 0.432 mg;SODIUM PHOSPHATE, DIBASIC, DIHYDRATE 0.816 mg;HYDROXYPROPYL CELLULOSE 6.24 mg;LACTOSE 8.16 mg;HYPROMELLOSE 11.81 mg;STARCH, CORN 24.96 mg;HYPROMELLOSE PHTHALATE (31% PHTHALATE, 170 CST) 25.18 mg;SUCROSE 142.26 mg |
| Dosage form | Capsule, Delayed Release |
| Manufacturer | Corporacion Infarmasa |
| NDC | 16853-1308 |
| Schedule | — |
| Availability | — |
| Ingredients | OMEPRAZOLE[Omeprazole];DIETHYL PHTHALATE[];SODIUM LAURYL SULFATE[];SODIUM PHOSPHATE, DIBASIC, DIHYDRATE[];HYDROXYPROPYL CELLULOSE[];LACTOSE[];HYPROMELLOSE[];STARCH, CORN[];HYPROMELLOSE PHTHALATE (31% PHTHALATE, 170 CST)[];SUCROSE[] |
What does this imprint mean?
The imprint "None" is a code stamped or printed on the tablet or capsule by the manufacturer, used to identify the drug, its strength and the maker.
Active ingredient
Omeprazole
Uses and warnings
Key safety concerns include: - Gastric Malignancy: "Symptomatic response does not preclude the presence of gastric malignancy" - Acute Tubulointerstitial Nephritis: Possible kidney inflammation requiring discontinuation - C. difficile Diarrhea: "Associated with increased risk" in hospitalized patients - Bone Fractures: Long-term, high-dose therapy linked to osteoporosis-related fractures - Severe Skin Reactions: Stevens-Johnson syndrome and toxic epidermal necrolysis reported - Lupus: Both cutaneous and systemic lupus erythematosus cases documented - Clopidogrel Interaction: "Avoid concomitant use"; reduces antiplatelet effectiveness - Vitamin B-12 Deficiency: Prolonged use may impair cyanocobalamin absorption - Hypomagnesemia: Serious cases including arrhythmias and seizures reported - Fundic Gland Polyps: Risk increases with long-term use beyond one year
Omeprazole is indicated for: - "Treatment of active duodenal ulcer in adults" - "Eradication of Helicobacter pylori to reduce the risk of duodenal ulcer recurrence" - "Treatment of active benign gastric ulcer in adults" - Treatment of symptomatic GERD in patients 1 year and older - "Treatment of erosive esophagitis (EE) due to acid-mediated GERD" in patients 1 month and older - Maintenance of EE healing in patients 1 year and older - "Long-term treatment of pathological hypersecretory conditions" such as Zollinger-Ellison syndrome
How to identify this pill
- • Check the imprint matches exactly: "None".
- • Confirm the colour (RED) and shape (CAPSULE).
- • Compare the size (17) against a ruler if possible.
- • When in doubt, confirm with a pharmacist before taking any medication.
Similar-looking pills
BP 301
RED CAPSULE · Folic Acid
IG273 5
RED CAPSULE · Ramipril
L454
RED CAPSULE · Acetaminophen
44 519
RED CAPSULE · Acetaminophen
L922
RED CAPSULE · Acetaminophen
TEVA 3171
RED CAPSULE · Clindamycin
H 148
RED CAPSULE · Lisinopril
5MG
RED CAPSULE · Zolpidem
GG 580
RED CAPSULE · Hydrochlorothiazide
L 5
RED CAPSULE · Acetaminophen
CE273 5mg
RED CAPSULE · Ramipril
SMV 80
RED CAPSULE · Simvastatin
Other pills of Omeprazole
APO 020
PINK CAPSULE · Omeprazole
MYLAN 6150
GREEN;BLUE CAPSULE · Omeprazole
APO 020
PINK;BROWN CAPSULE · Omeprazole
APO 040
PINK;BROWN CAPSULE · Omeprazole
Omeprazole 10mg
WHITE CAPSULE · Omeprazole
APO 040
BROWN;PINK CAPSULE · Omeprazole
20
BROWN OVAL · Omeprazole
20
BROWN OVAL · Omeprazole
E 69
BROWN CAPSULE · Omeprazole
20
BROWN OVAL · Omeprazole
OM20 ap
WHITE CAPSULE · Omeprazole
20
BROWN OVAL · Omeprazole
Official references
Source: FDA Structured Product Label via NLM Pillbox archive (retired 2021); source file b16d55b9-70a2-4734-a8f4-bfd1cd108be4.xml